CBD Life Sciences Inc.
CBDL - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$375.39K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $375,394.00 |
|---|---|
| Enterprise Value | $-104,277.00 |
| Earnings per Share | $0 |
| Beta | -0.59 |
| Outstanding Shares | 6,110,570,155 |
Return
| Return on Equity | -1.90% |
|---|---|
| Return on Assets | -2.05% |
| Return on Invested Capital | -12.56% |
Valuation & Multiples
| P/E Ratio | -115.13 |
|---|---|
| PEG | 99.13 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -1.11 |
| Enterprise Value to EBIT | 1.51 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | -0.01 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About CBD Life Sciences Inc.
3 employees
CEO: Lisa Anne Nelson
CBD Life Sciences Inc. specializes in formulating and distributing a broad array of organic items infused with cannabidiol. Their extensive range of natural CBD offerings includes hemp tinctures, topical massage oils, targeted recovery a...